1. Home
  2. GFAI vs TOVX Comparison

GFAI vs TOVX Comparison

Compare GFAI & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

HOLD

Current Price

$0.33

Market Cap

15.9M

ML Signal

HOLD

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.24

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFAI
TOVX
Founded
2018
2001
Country
Singapore
United States
Employees
N/A
16
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
11.1M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
GFAI
TOVX
Price
$0.33
$0.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.50
$1.00
AVG Volume (30 Days)
193.4K
425.7K
Earning Date
04-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.07
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.12
N/A
Revenue Next Year
$10.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.16
52 Week High
$1.38
$0.86

Technical Indicators

Market Signals
Indicator
GFAI
TOVX
Relative Strength Index (RSI) 35.06 47.77
Support Level $0.31 $0.22
Resistance Level $0.41 $0.26
Average True Range (ATR) 0.02 0.01
MACD -0.01 -0.00
Stochastic Oscillator 2.50 39.25

Price Performance

Historical Comparison
GFAI
TOVX

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Share on Social Networks: